Table 1. Relationship between CA IX expression and clinico-pathological features.
| Variables | Total | 1–25% | 26–50% | 51–75% | 76–100% | P-valuea |
|---|---|---|---|---|---|---|
| Age tertile | NSb | |||||
| <61 | 20 | 6 | 5 | 6 | 3 | |
| 61.1–71.9 | 22 | 7 | 8 | 3 | 4 | |
| ⩾72 | 30 | 3 | 14 | 10 | 3 | |
| Type | NS | |||||
| Nonmucinous | 66 | 15 | 23 | 18 | 10 | |
| Mucinous | 6 | 1 | 4 | 1 | ||
| Site | NS | |||||
| Left colon | 3 | 1 | 1 | 1 | ||
| Caecum | 17 | 4 | 8 | 5 | ||
| Right colon | 4 | 1 | 1 | 1 | 1 | |
| Transverse, splenic | 3 | 1 | 2 | |||
| Rectum | 24 | 5 | 8 | 8 | 3 | |
| Rectum-sigmoid | 8 | 2 | 3 | 1 | 2 | |
| Sigmoid | 13 | 4 | 5 | 3 | 1 | |
| Size median | NS | |||||
| <Median | 28 | 5 | 11 | 10 | 2 | |
| ⩾Median | 44 | 11 | 16 | 9 | 8 | |
| Dukes' stage | <0.01 | |||||
| A | 18 | 10 | 3 | 4 | 1 | |
| B | 32 | 6 | 21 | 4 | 1 | |
| C | 22 | 3 | 11 | 8 | ||
| Differentiation | 0.01 | |||||
| Moderate | 4 | 1 | 1 | 1 | 1 | |
| Well | 62 | 14 | 25 | 18 | 5 | |
| Poor | 6 | 1 | 1 | 3 | 1 | |
| Metastasis | 0.01 | |||||
| Primary | 72 | 16 | 27 | 19 | 10 | |
| Secondary | 13 | 2 | 5 | 4 | 2 | |
| Lymphatic metastasis | 0.01 | |||||
| At DXc | 24 | 1 | 4 | 11 | 8 | |
| During FUd | 2 | 1 | 1 | |||
| No metastasis | 46 | 14 | 22 | 8 | 2 | |
| Vascular metastasis | 0.05 | |||||
| <Median | 37 | 6 | 16 | 9 | 6 | |
| ⩾Median | 35 | 10 | 11 | 10 | 4 | |
| Lymph node metastasis | 0.02 | |||||
| No | 43 | 14 | 20 | 8 | 1 | |
| Yes | 29 | 2 | 7 | 11 | 9 | |
| Death | 0.03 | |||||
| No | 28 | 10 | 9 | 6 | 3 | |
| Yes | 44 | 6 | 18 | 13 | 7 | |
| Recurrence | 0.02 | |||||
| Yes | 25 | 1 | 9 | 9 | 6 | |
| No | 42 | 14 | 17 | 8 | 3 | |
| NA | 5 | 1 | 1 | 2 | 1 | |
| Gender | NS | |||||
| Male | 42 | 9 | 13 | 13 | 7 | |
| Female | 30 | 7 | 14 | 6 | 3 | |
P-value by multivariate regression analysis.
Not significant.
At Dukes' C.
Nodal recurrence.